# | Drug | Count |
---|---|---|
0 | ATENOLOL | 3 |
1 | BISOPROLOL FUMARATE | 3 |
2 | ADALIMUMAB | 2 |
3 | ASPIRIN | 2 |
4 | ASPIRIN 325 MG | 2 |
5 | ASPIRIN 81 MG | 2 |
6 | ASPIRIN TABLET 325MG | 2 |
7 | CYCLOBENZAPRINE | 2 |
8 | CYCLOBENZAPRINE HYDROCHLORIDE | 2 |
9 | CYCLOPHOSPHAMIDE | 2 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | PYRIMETHAMINE | 1 | 0.0010 |
1 | IDARUCIZUMAB | 1 | 0.0008 |
2 | MARC GLASSMAN | 1 | 0.0003 |
3 | DOCUSATE CALCIUM | 1 | 0.0002 |
4 | TOPOTECAN | 1 | 0.0002 |
5 | TAMOXIFEN CITRATE | 1 | 0.0002 |
6 | DOCUSATE SODIUM AND SENNOSIDES | 1 | 0.0002 |
7 | RUCAPARIB | 1 | 0.0001 |
8 | NIRAPARIB | 2 | 0.0001 |
9 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0001 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0010 |
1 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0008 |
2 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
3 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 2 | 0.0001 |
4 | Cardiac Glycoside [EPC] | 2 | 0.0000 |
5 | Methylxanthine [EPC] | 1 | 0.0000 |
6 | Complement Inhibitor [EPC] | 1 | 0.0000 |
7 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
8 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
9 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |